Medket: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Medket
Largest movements
- Deferred charges and accrued income -€5,610
down €5,610 (-23.5%), from €23,918 to €18,308
- Tangible fixed assets -€5,251
down €5,251 (-35.9%), from €14,639 to €9,388
of which Furniture and vehicles: -€3,592
- Cash +€4,892
up €4,892 (+11.2%), from €43,599 to €48,491
mainly Net result for the year (+€79,093) and Depreciation (+€6,450)
- Other debts -€5,479
down €5,479 (-6.4%), from €85,710 to €80,231
- Gross operating margin -€2,085
down €2,085 (-1.9%), from €109,499 to €107,414
- Financial income -€1,794
no longer reported in 2025 (was €1,794)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €91,298 | €85,452 | -€5,846 | -6.4% |
| Fixed assets | 21/28 | €14,889 | €9,638 | -€5,251 | -35.3% |
| Tangible fixed assets | 22/27 | €14,639 | €9,388 | -€5,251 | -35.9% |
| Land and buildings | 22 | €689 | €338 | -€351 | -50.9% |
| Plant, machinery and equipment | 23 | €7,423 | €6,115 | -€1,308 | -17.6% |
| Furniture and vehicles | 24 | €6,526 | €2,934 | -€3,592 | -55.0% |
| Financial fixed assets | 28 | €250 | €250 | = | 0.0% |
| Current assets | 29/58 | €76,409 | €75,814 | -€595 | -0.8% |
| Amounts receivable within one year | 40/41 | €8,892 | €9,016 | +€123 | +1.4% |
| Trade receivables | 40 | €8,331 | €7,264 | -€1,067 | -12.8% |
| Other amounts receivable | 41 | €561 | €1,751 | +€1,190 | +212% |
| Cash at bank and in hand | 54/58 | €43,599 | €48,491 | +€4,892 | +11.2% |
| Deferred charges and accrued income | 490/1 | €23,918 | €18,308 | -€5,610 | -23.5% |
| Total equity and liabilities | 10/49 | €91,298 | €85,452 | -€5,846 | -6.4% |
| Equity | 10/15 | €3,000 | €3,000 | = | 0.0% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Amounts payable | 17/49 | €88,298 | €82,452 | -€5,846 | -6.6% |
| Amounts payable within one year | 42/48 | €88,251 | €82,452 | -€5,798 | -6.6% |
| Trade debts | 44 | €2,540 | €2,221 | -€319 | -12.6% |
| Suppliers | 440/4 | €2,540 | €2,221 | -€319 | -12.6% |
| Other amounts payable | 47/48 | €85,710 | €80,231 | -€5,479 | -6.4% |
| Accrued charges and deferred income | 492/3 | €47 | - | -€47 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,217 | €6,450 | -€767 | -10.6% |
| Other operating charges | 640/8 | €936 | €774 | -€161 | -17.2% |
| Gross operating margin | 9900 | €109,499 | €107,414 | -€2,085 | -1.9% |
| Operating profit (loss) | 9901 | €101,346 | €100,190 | -€1,156 | -1.1% |
| Financial income | 75/76B | €1,794 | - | -€1,794 | |
| Recurring financial income | 75 | €1,794 | - | -€1,794 | |
| Financial charges | 65/66B | €511 | €287 | -€224 | -43.9% |
| Recurring financial charges | 65 | €511 | €287 | -€224 | -43.9% |
| Profit (loss) for the period before taxes | 9903 | €102,629 | €99,903 | -€2,726 | -2.7% |
| Income taxes | 67/77 | €21,439 | €20,810 | -€629 | -2.9% |
| Profit (loss) for the period | 9904 | €81,190 | €79,093 | -€2,097 | -2.6% |
| Profit (loss) for the period to be appropriated | 9905 | €81,190 | €79,093 | -€2,097 | -2.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.